Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells-Reference-Cited by-同舟云学术

Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells

Published:2007-03-15 Issue:2 Volume:84 Page:131-140
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

De Vleeschouwer Steven,Spencer Lopes Isabel,Ceuppens Jan L.,Van Gool Stefaan W.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-007-9362-y.pdf

Reference43 articles.

1. Fleury A, Menegoz F, Grosclaude P, Daures JP, Henry Amar M, Raverdy N, Schaffer P, Poisson M, Delattre JY (1997) Descriptive epidemiology of cerebral gliomas in France. Cancer 79:1195–1202

2. Tamber MS, Rutka JT (2003) Pediatric supratentorial high-grade gliomas. Neurosurg Focus 14: http://www.medscape.com/viewarticle/449870

3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoom MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer EA, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Eng J Med 352:987–996

4. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC (1995) Histopathology, classification, and grading of gliomas. Glia 15:211–221

5. Siesjo P, Visse E, Sjogren HO (1996) Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment. J Immunother Emphasis Tumor Immunol 19:334–345

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive MDSC and Treg signatures predict prognosis and therapeutic response in glioma;International Immunopharmacology;2024-11

2. Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients;Methods in Cell Biology;2023

3. Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape;Cancers;2021-12-13

4. IL-10 in glioma;British Journal of Cancer;2021-08-04

5. Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy;Cancer Letters;2021-01